Fundraising FoxForesite Capital — 2026 Investments
6 investments dated 2026 · listed companies and verified rows first · show all
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Founder)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+9 more
Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.
BiotechDeep TechHealthtechLongevity
Nils Regge(Co-Founder & General Partner)in
Co-investorsBLN CapitalCoastCapFelix JahnFJ LabsKfW CapitalQuery Capital+5 more
MIDI develops digital health solutions for patients and clinicians to improve access to and delivery of care across diverse populations.
Digital HealthHealthtechLos Altos Hills, US
Joanna Stober(Executive Officer, Director)Sharon Meers(President & Co-founder)inJoanna Strober(Founder)inKathleen Jordan MD(Chief Medical Officer & Co-founder)inKathleen Jordan(Founder)
BoardAllison Gates(Director)in
Co-investors1843 Capital25MadisonAble PartnersAdvance Venture PartnersAvestria VenturesCity Light+19 more
Oncology Ventures is a cancer-focused venture capital fund that invests in healthcare technology startups related to oncology care.
AI & Machine LearningBiotechDigital HealthHealthtech
Ben Freeberg(Founder, Managing Partner)inJay Freeberg(Chief Financial Officer)
Co-investorsSandwich CapitalAlleyCorpCanaan PartnersConcord Health PartnersCVS Health VenturesForbion+5 more
Pinnacle Medicines develops oral peptide-based therapies designed to deliver antibody-like efficacy in pill form for patients with chronic diseases.
BiotechDigital HealthDoylestown, US
Chengzao Sun(Founder)inSandeep Somani(Founder)in
Co-investorsQuan CapitalRA CapitalLAVOrbiMedVenrock
Slate Medicines is a clinical-stage biotechnology company.
BiotechMedical DevicesBoston, US
Sara Pacheco(Executive Officer)Neil Buckley(Executive Officer, Director)inGregory Oakes(Chief Executive Officer and Board Director)in
BoardTim Lohoff(Director)Cindy Xiong(Director)inAndrew Levin(Director)
Co-investorsRA CapitalVenrock
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.